ComforTrate (Maropitant Citrate) Antiemetic Tablets for Dogs: 160mg

Relieves Vomiting and Motion Sickness in Dogs

Product Description

ComforTrate (maropitant citrate) Antiemetic Tablets for Dogs are veterinarian-prescribed oral tablets designed to help prevent acute vomiting and vomiting caused by motion sickness. The active ingredient, maropitant citrate, works by blocking substance P in the brain’s vomiting center to control nausea signals. This targeted mechanism provides effective antiemetic support for dogs when recommended by a licensed veterinarian.

Benefits

• Prevents Vomiting: Blocks signals in the brain that trigger the vomiting reflex and thus prevent acute vomiting in dogs.
• Motion Sickness Control: Reduces vomiting associated with travel-related motion sickness when administered before a journey.
• Targets Vomiting Pathway: Maropitant works by blocking NK1 receptors and inhibiting substance P activity in the central nervous system.
• Convenient Once Daily Dose: Tablets are designed for once daily oral dosing according to veterinary instructions for vomiting prevention.)
• Multiple Strength Options: Available in several tablet strengths to support accurate dosing based on the dog’s body weight.

Variants

160 mg tablets

Ingredients

Maropitant (as maropitant citrate) 160 mg

How to Use

Recommended-Dosage Chart

Acute Vomiting (Minimum Dose 2 mg/kg once daily)

Vomiting Due to Motion Sickness (Minimum Dose 8 mg/kg once daily)

Dosage & Administration Instructions

• Veterinary Prescription Required: This medication is restricted to use by or on the order of a licensed veterinarian.
• Acute Vomiting Dose: Administer orally, beginning with at least 2 mg/kg of body weight, once daily.
• Treatment Duration: For dogs, 2 to 7 months, use once daily for up to five consecutive days.
• Motion Sickness Dose: Administer at least 8 mg/kg orally once daily to prevent vomiting due to motion sickness.
• Pre Travel Timing: Give tablets at least two hours before travel with a small amount of food.
• Active Vomiting Cases: Injectable maropitant may be used initially to ensure full dosing in actively vomiting dogs.

Disclaimer: This dosage information is provided by the manufacturer. Always consult your veterinarian before administering or adjusting any supplement for your pet.

Additional Information

Precautions

• Human Safety Warning: Not for human use. Keep out of reach of children and wash hands after administering tablets.
• Young Puppy Risk: Puppies younger than 11 weeks showed a higher rate of bone marrow hypocellularity during studies.
• Liver Disease Caution: Use carefully in dogs with liver issues since maropitant is broken down by CYP3A enzymes.
• Drug Interaction Risk: Be careful when giving it with medications that are highly protein-bound, such as NSAIDs or heart medications.
• Underlying Cause Evaluation: Identify and treat the cause of vomiting to improve treatment effectiveness.
• Breeding Safety Unknown: Safety has not been tested in breeding, pregnant, or nursing dogs.

Possible Side Effects

• Digestive Issues: Some dogs might face problems like diarrhea, vomiting, or even bloody stools while undergoing treatment.
• Excessive Drooling: Some dogs taking maropitant tablets have shown signs of increased salivation.
• Decreased Appetite: Drop in appetite and some weight loss, which can happen due to the dosage.
• Behavioral Changes: In rare instances, dogs may exhibit sedation, depression, or even hyperactivity.
• Neurological Symptoms: Reports have indicated that trembling, uncoordinated movements, or lethargy can happen.

Storage Information

• Room Temperature Storage: Store tablets at controlled room temperature between 20°C and 25°C.
• Temperature Range: Short-term exposure within permitted temperature ranges is acceptable without affecting product quality.
• Secure Storage: Keep tablets stored away from pets' reach to prevent accidental ingestion or overdose.

Shipping & Return

We offer ground, express, priority, and international delivery; see our shipping policy for details.

For return instructions or product concerns, please refer to our detailed refund policy. 

Prescription items are NON-RETURNABLE and NON-REFUNDABLE.

Frequently Asked Questions

Q1: What is ComforTrate used for in dogs?

Ans: ComforTrate (maropitant citrate) tablets are used to help prevent acute vomiting and motion sickness-related vomiting in dogs. The medication blocks neurokinin-1 receptors in the brain, preventing substance P from triggering the vomiting reflex and helping control nausea when administered as directed by a veterinarian.

Q2: How does ComforTrate help control vomiting in dogs?

Ans: ComforTrate contains maropitant citrate, which works by blocking neurokinin-1 receptors in the central nervous system. This action prevents substance P from binding in the vomiting center of the brain, reducing signals that trigger vomiting caused by both central and peripheral stimuli.

Q3: How should ComforTrate tablets be given to dogs for motion sickness?

Ans: To help prevent motion sickness, it's recommended to take ComforTrate tablets orally, starting with a minimum dose of 8 mg/kg once a day for up to two days in a row. Make sure to take the dose at least two hours before you travel, and it's best to have it with a small meal.

Q4: Can ComforTrate be given to puppies?

Ans: ComforTrate may be used in dogs aged 2 months and older for acute vomiting, depending on veterinary guidance. However, caution is advised in puppies younger than 11 weeks because bone marrow changes were observed more frequently in safety studies.

Q5: Do dogs need a prescription to use ComforTrate tablets?

Ans: Yes. ComforTrate tablets are classified as a prescription medication, and federal law limits their use to administration by or on the order of a licensed veterinarian. It's important for pet owners to consult with their veterinarian before starting or changing this medication.